NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) announced the European Patent Office’s (EPO) issuance of a...
Business
Business
NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) announced the European Patent Office’s (EPO) issuance of a...